Paul Tudor Jones's BNTX Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 2,957 shares of BioNTech SE (BNTX) worth $281,506, representing 0.00% of the portfolio. First purchased in 2021-Q1, this medium-term investment has been held for 11 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in BNTX, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2022, adding 5,123 shares. Largest reduction occurred in Q1 2023, reducing 5,123 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's BioNTech SE (BNTX) Holding Value Over Time
Track share changes against reported price movement
Quarterly BioNTech SE (BNTX) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +2,957 | New Buy | 2,957 | $95.20 |
| Q4 2023 | -2,934 | Sold Out | 0 | $0.00 |
| Q3 2023 | +2,934 | New Buy | 2,934 | $108.64 |
| Q1 2023 | -5,123 | Sold Out | 0 | $0.00 |
| Q4 2022 | +5,123 | New Buy | 5,123 | $0.15 |
| Q3 2022 | -2,257 | Sold Out | 0 | $0.00 |
| Q2 2022 | +2,257 | New Buy | 2,257 | $149.31 |
| Q4 2021 | -1,853 | Sold Out | 0 | $0.00 |
| Q3 2021 | +1,853 | New Buy | 1,853 | $273.07 |
| Q2 2021 | -5,046 | Sold Out | 0 | $0.00 |
| Q1 2021 | +5,046 | New Buy | 5,046 | $109.20 |
Paul Tudor Jones's BioNTech SE Investment FAQs
Paul Tudor Jones first purchased BioNTech SE (BNTX) in Q1 2021, acquiring 5,046 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held BioNTech SE (BNTX) for 11 quarters since Q1 2021.
Paul Tudor Jones's largest addition to BioNTech SE (BNTX) was in Q4 2022, adding 5,123 shares worth $770.
According to the latest 13F filing for Q4 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 2,957 shares of BioNTech SE (BNTX), valued at approximately $281,506.
As of the Q4 2025 filing, BioNTech SE (BNTX) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in BioNTech SE (BNTX) was 5,123 shares, as reported at the end of Q4 2022.